{"id":7117,"date":"2025-02-18T16:40:48","date_gmt":"2025-02-18T16:40:48","guid":{"rendered":"https:\/\/apgi.org\/?post_type=agenda&#038;p=7117"},"modified":"2025-04-03T16:03:28","modified_gmt":"2025-04-03T16:03:28","slug":"info-day-15-may-2025-in-paris","status":"publish","type":"agenda","link":"https:\/\/apgi.org\/fr\/agenda\/info-day-15-may-2025-in-paris\/","title":{"rendered":"Info day &#8211; 15 May 2025 in Paris"},"content":{"rendered":"\n<h2 class=\"wp-block-heading has-text-align-center has-blue-color has-text-color\">Pharmaceutical Industry and Nitrosamines: from Risk Assessments to Control Strategies<\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img decoding=\"async\" src=\"https:\/\/apgi.org\/uploads\/2025\/02\/Nitrosamine-schema.jpg\" alt=\"\" class=\"wp-image-7160\"\/><\/figure>\n<\/div>\n\n\n<p class=\"has-text-align-center\">organized with<\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-image\">\n<figure class=\"alignright size-large is-resized\"><img decoding=\"async\" src=\"https:\/\/apgi.org\/uploads\/2025\/03\/Colorcon_Logo_RGB-1024x485.jpg\" alt=\"\" class=\"wp-image-7329\" style=\"width:150px\"\/><\/figure>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-image\">\n<figure class=\"alignleft size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/apgi.org\/uploads\/2025\/02\/JRS-1.jpg\" alt=\"\" class=\"wp-image-7180\" style=\"aspect-ratio:3.2839506172839505;object-fit:cover;width:180px\"\/><\/figure>\n<\/div><\/div>\n<\/div>\n\n\n\n<p><span style=\"color: #00387a;\">The Introduction will open the day by addressing the context and regulatory environment<br \/><\/span><span style=\"color: #00387a;\">\u2022 Approach to excipient-related aspects (starch and MCC)<br \/><\/span><span style=\"color: #00387a;\">\u2022 Quality management approach<br \/><\/span><span style=\"color: #00387a;\">\u2022 Challenges in the analytical dosing of nitrosamines in excipients<br \/><\/span><span style=\"color: #00387a;\">\u2022 Risk analysis and strategies used by the Pharmaceutical Industry to avoid analytical dosage of nitrosamines (case studies on active ingredients APIs and finished dosage forms FDF)\u00a0<br \/><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pharmaceutical Industry and Nitrosamines: from Risk Assessments to Control Strategies organized with The Introduction will open the day by addressing the context and regulatory environment\u2022 Approach to excipient-related aspects (starch and MCC)\u2022 Quality management approach\u2022 Challenges in the analytical dosing of nitrosamines in excipients\u2022 Risk analysis and strategies used by the Pharmaceutical Industry to avoid [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","cat_location":[],"research_field":[],"class_list":["post-7117","agenda","type-agenda","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/apgi.org\/fr\/wp-json\/wp\/v2\/agenda\/7117","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/apgi.org\/fr\/wp-json\/wp\/v2\/agenda"}],"about":[{"href":"https:\/\/apgi.org\/fr\/wp-json\/wp\/v2\/types\/agenda"}],"version-history":[{"count":2,"href":"https:\/\/apgi.org\/fr\/wp-json\/wp\/v2\/agenda\/7117\/revisions"}],"predecessor-version":[{"id":7367,"href":"https:\/\/apgi.org\/fr\/wp-json\/wp\/v2\/agenda\/7117\/revisions\/7367"}],"wp:attachment":[{"href":"https:\/\/apgi.org\/fr\/wp-json\/wp\/v2\/media?parent=7117"}],"wp:term":[{"taxonomy":"cat_location","embeddable":true,"href":"https:\/\/apgi.org\/fr\/wp-json\/wp\/v2\/cat_location?post=7117"},{"taxonomy":"research_field","embeddable":true,"href":"https:\/\/apgi.org\/fr\/wp-json\/wp\/v2\/research_field?post=7117"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}